1585PDNA damage repair deficiency is associated with early resistance to crizotinib: Whole-genome analysis in non-small cell lung cancer patients with ALK-fusion
ConclusionsThus, DDR deficiency may contribute to the early resistance to crizotinib in ALK-fusion patients.Legal entity responsible for the studyThe authors.FundingHas not received any funding.DisclosureAll authors have declared no conflicts of interest.
Source: Annals of Oncology - Category: Cancer & Oncology Source Type: research
More News: Cancer | Cancer & Oncology | Gastroschisis Repair | Genetics | Legislation | Lung Cancer | Non-Small Cell Lung Cancer